Cargando…

Nevirapine-associated liver toxicity and hypersensitivity reactions in a cohort of HIV-1-infected patients,clinical analysis

Detalles Bibliográficos
Autores principales:	Jonckheere, Sylvie, Yombi, JC, Belkhir, Leila, Vincent, Anne, Vandercam, Bernard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3360377/ http://dx.doi.org/10.1186/1742-4690-9-S1-P10

Ejemplares similares

HIV-associated multicentric castelman disease, a report of 5 cases
por: Jonckheere, Sylvie, et al.
Publicado: (2012)

Low reduction of HCV-RNA level at week 4 in HIV-1 infected patients with acute HCV Infection
por: Vincent, A, et al.
Publicado: (2012)

Genome-wide association study of nevirapine hypersensitivity in a malawian HIV-infected population
por: Carr, Daniel, et al.
Publicado: (2014)

Streptococcus gordonii septic arthritis : two cases and review of literature
por: Yombi, Jean cyr, et al.
Publicado: (2012)

Population pharmacokinetic and pharmacogenetic analysis of nevirapine in hypersensitive and tolerant HIV-infected patients from Malawi
por: Dickinson, L, et al.
Publicado: (2010)

Cutaneous drug-reactions to nevirapine: study of risk factors in 268 HIV-infected patients
por: Badaoui, L, et al.
Publicado: (2014)

Lopinavir/r + Efavirenz combination as a potent NRTI sparing antiretroviral therapy
por: Henrivaux, Philippe, et al.
Publicado: (2010)

Interaction between Darunavir and Etravirine Is Partly Mediated by CYP3A5 Polymorphism
por: Belkhir, Leïla, et al.
Publicado: (2016)

Exploration of Reduced Doses and Short-Cycle Therapy for Darunavir/Cobicistat in Patients with HIV Using Population Pharmacokinetic Modeling and Simulations
por: Stillemans, Gabriel, et al.
Publicado: (2020)

48-week efficacy and safety of transitioning virologically stable HIV-1 patients from nevirapine IR 200 mg BID to nevirapine XR 400 mg QD (TRANxITION)
por: Arastéh, K, et al.
Publicado: (2010)

CD4 response, lipid changes and liver outcome in 506 patients receiving nevirapine-based regimens for a median of 9 years
por: Podzamczer, D, et al.
Publicado: (2010)

Liver safety of two nucleoside analogs plus efavirenz, nevirapine or a ritonavir-boosted protease inhibitor in HIV/HCV-coinfected drug-naïve patients
por: Macías, J, et al.
Publicado: (2010)

Comparative efficacy and safety of regimens including ritonavir-boosted lopinavir or nevirapine in antiretroviral-naïve HIV-1-infected individuals
por: Pereira, A, et al.
Publicado: (2010)

Temporal trend of the first prescription of nevirapine: the ANRS CO3 Aquitaine Cohort, 1997-2008
por: Bruyand, M, et al.
Publicado: (2010)

Auto immune haemolytic anaemia as part of Nevirapine induced DRESS syndrome
por: Reghukumar, Aravind, et al.
Publicado: (2014)

Optimal sampling strategies for darunavir and external validation of the underlying population pharmacokinetic model
por: Stillemans, Gabriel, et al.
Publicado: (2020)

Clinical characteristics and humoral immune response in healthcare workers with COVID-19 in a teaching hospital in Belgium
por: Vandercam, G., et al.
Publicado: (2020)

The causative drugs and the prevalence of severe bullous hypersensitivity reactions
por: Vertieva, Ekaterina, et al.
Publicado: (2014)

The predictive value of the in vitro platelet toxicity assay (iPTA) for the diagnosis of hypersensitivity reactions to sulfonamides: a case-control study
por: Elzagallaai, Abdelbaset, et al.
Publicado: (2014)

Rapid desensitization in delayed hypersensitivity reactions to chemotherapy and monoclonal antibodies
por: Vega, Arantza, et al.
Publicado: (2014)

Multiple drug hypersensitivity associated with severe cutaneous adverse reaction
por: Lin Choo, Karen Jui, et al.
Publicado: (2014)

The effects of highly active antiretroviral therapy (HAART) of stavudine, lamivudine and nevirapine on the CD4 lymphocyte count of HIV-infected Africans: the Nigerian experience
por: Erhabor, Osaro, et al.
Publicado: (2009)

Comparing the effectiveness of efavirenz and nevirapine for first-line antiretroviral treatment amongst an adult treatment cohort from South Africa
por: Bock, P, et al.
Publicado: (2010)

Severe hypersensitivity reactions to iodinated contrast media: clinical and immunological features in a cohort of patients
por: Rivero Paparoni, Daniela, et al.
Publicado: (2014)

Hypersensitivity reactions to biologic disease modifying antirheumatic drugs: experience from the TTSH Singapore biologics registry
por: Thong, Bernard, et al.
Publicado: (2014)

Effectiveness of premedication for hypersensitivity reactions to radiocontrast media in one tertiary hospital
por: Jung, JaeWoo, et al.
Publicado: (2014)

Drug hypersensitivity to various antihistamines with cross-reactions: a case report
por: Lee, Jaechun, et al.
Publicado: (2014)

Impact of UGT1A1 polymorphisms on Raltegravir and its glucuronide plasma concentrations in a cohort of HIV-1 infected patients
por: Belkhir, Leïla, et al.
Publicado: (2018)

Beta lactam hypersensitivities
por: Azoury, Marie Eliane*, et al.
Publicado: (2014)

P25 - Hypersensitivity/adverse reactions to antituberculosis drugs – a case report
por: Barrosa Maia, Estefânia, et al.
Publicado: (2014)

Analysis of cross-reactivity between radio -contrast media in 97 hypersensitivity reactions
por: Lerondeau, Berangere, et al.
Publicado: (2014)

Involvement of the activating receptor NKG2D in cutaneous hypersensitivity drug reactions
por: Bellón, Teresa, et al.
Publicado: (2014)

Influence of liver fibrosis stage on nevirapine plasma concentration in HIV-infected patients with chronic hepatitis C virus
por: Dragovic, Gordana, et al.
Publicado: (2014)

Sex differences in apolipoprotein A1 and nevirapine-induced toxicity
por: Marinho, Aline, et al.
Publicado: (2014)

Association of Human Leukocyte Antigen Alleles and Nevirapine Hypersensitivity in a Malawian HIV-Infected Population
por: Carr, Daniel F., et al.
Publicado: (2013)

Population Pharmacokinetic and Pharmacogenetic Analysis of Nevirapine in Hypersensitive and Tolerant HIV-Infected Patients from Malawi
por: Dickinson, Laura, et al.
Publicado: (2014)

The incidence of hypersensitivity reactions to non-steroidal anti-inflammatory drugs in patients with chronic urticaria
por: Kolkhir, Pavel, et al.
Publicado: (2014)

T cell activation in biological diagnosis of amoxicillin delayed hypersensitivity
por: de Chaisemartin, Luc, et al.
Publicado: (2014)

Switching to nevirapine (NVP) significantly increases high-density lipoprotein cholesterol (HDL-C) in treatment-experienced patients (NEVICOR study)
por: Rodriguez, JM, et al.
Publicado: (2010)

Genome-wide association study of nevirapine hypersensitivity in a sub-Saharan African HIV-infected population
por: Carr, Daniel F., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_iehug7apctprrf5fe6u745jv7t